Drug shortages homepage
Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.
Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.
The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.
Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.
If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.
Below are the newest shortage and discontinuation reports and updates to existing ones.
LEGEND
!!T3 denotes an actual Tier 3 shortage/discontinuation
!T3 denotes an anticipated Tier 3 shortage/discontinuation
Shortage Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
PROCYTOX | BAXTER CORPORATION | Actual shortage | 2000MG | Updated Report | 2024-05-02 | 225670 |
PROPOFOL INJECTION | BAXTER CORPORATION | Actual shortage | 10MG | Updated Report | 2024-05-02 | 225667 |
MYOVIEW 30ML | GE HEALTHCARE CANADA INC | Anticipated shortage | 1.38MG | New Report | 2024-05-02 | 226858 |
RIVA-ANASTROZOLE | LABORATOIRE RIVA INC. | Anticipated shortage | 1MG | Updated Report | 2024-05-02 | 217917 |
CHAMPIX | PFIZER CANADA ULC | Resolved | 1MG 0.5MG | Updated Report | 2024-05-02 | 138922 |
CHAMPIX | PFIZER CANADA ULC | Resolved | 1MG | Updated Report | 2024-05-02 | 138919 |
CHAMPIX | PFIZER CANADA ULC | Resolved | 0.5MG | Updated Report | 2024-05-02 | 138662 |
MAGNESIUM SULFATE INJECTION, USP | FRESENIUS KABI CANADA LTD | Resolved | 500MG | Updated Report | 2024-05-02 | 217935 |
M-PERINDOPRIL ERBUMINE | MANTRA PHARMA INC | Resolved | 8MG | Updated Report | 2024-05-02 | 225542 |
M-ESCITALOPRAM | MANTRA PHARMA INC | Resolved | 20MG | Updated Report | 2024-05-02 | 225524 |
M-BETAHISTINE | MANTRA PHARMA INC | Resolved | 16MG | Updated Report | 2024-05-02 | 225585 |
M-BETAHISTINE | MANTRA PHARMA INC | Resolved | 8MG | Updated Report | 2024-05-02 | 225577 |
SERTRALINE | SANIS HEALTH INC | Resolved | 100MG | Updated Report | 2024-05-02 | 220633 |
ZAVESCA | JANSSEN INC | Resolved | 100MG | Updated Report | 2024-05-02 | 225362 |
VFEND | PFIZER CANADA ULC | Actual shortage | 200MG | Updated Report | 2024-05-02 | 226796 |
QUETIAPINE XR | SIVEM PHARMACEUTICALS ULC | Actual shortage | 400MG | Updated Report | 2024-05-02 | 218001 |
SANDOZ DOCUSATE SODIUM | SANDOZ CANADA INCORPORATED | Resolved | 100MG | Updated Report | 2024-05-02 | 219987 |
MOXIFLOXACIN INJECTION | FRESENIUS KABI CANADA LTD | Actual shortage | 400MG | Updated Report | 2024-05-02 | 224325 |
SANDOZ OXYCODONE/ACETAMINOPHEN | SANDOZ CANADA INCORPORATED | Resolved | 325MG 5MG | Updated Report | 2024-05-02 | 224969 |
SANDOZ OXYCODONE/ACETAMINOPHEN | SANDOZ CANADA INCORPORATED | Resolved | 325MG 5MG | Updated Report | 2024-05-02 | 224972 |
SANDOZ D 10 000 | SANDOZ CANADA INCORPORATED | Resolved | 10000UNIT | Updated Report | 2024-05-02 | 225223 |
SENSORCAINE | ASPEN PHARMACARE CANADA INC. | Actual shortage | 2.5MG | Updated Report | 2024-05-02 | 225255 |
LETROZOLE | SIVEM PHARMACEUTICALS ULC | Actual shortage | 2.5MG | Updated Report | 2024-05-02 | 217986 |
AZITHROMYCIN | SANIS HEALTH INC | Resolved | 250MG | Updated Report | 2024-05-02 | 224788 |
CABLIVI | SANOFI-AVENTIS CANADA INC | Actual shortage | 11MG | Updated Report | 2024-05-02 | 225859 |
DEXMEDETOMIDINE HYDROCHLORIDE INJECTION | JUNO PHARMACEUTICALS CORP. | Actual shortage | 200MCG | Updated Report | 2024-05-02 | 225929 |
HYDROMORPHONE HYDROCHLORIDE INJECTION USP | PFIZER CANADA ULC | Actual shortage | 10MG | Updated Report | 2024-05-02 | 226090 |
LAYLAA 21 | LUPIN PHARMA CANADA LIMITED | Actual shortage | 0.02MG 0.1MG | Updated Report | 2024-05-02 | 226799 |
LAYLAA 28 | LUPIN PHARMA CANADA LIMITED | Actual shortage | 0.02MG 0.1MG | Updated Report | 2024-05-02 | 226802 |
APO-OLMESARTAN | APOTEX INC | Actual shortage | 20MG | Updated Report | 2024-05-02 | 216711 |
IMITREX | GLAXOSMITHKLINE INC | Resolved | 5MG | Updated Report | 2024-05-01 | 224362 |
IDARUBICIN | PFIZER CANADA ULC | Anticipated shortage | 1MG | New Report | 2024-05-01 | 226809 |
IDARUBICIN | PFIZER CANADA ULC | Anticipated shortage | 1MG | Updated Report | 2024-05-01 | 226805 |
DALACIN C FLAVOURED GRANULES | PFIZER CANADA ULC | Anticipated shortage | 75MG | New Report | 2024-05-01 | 226793 |
SURVANTA | ABBVIE CORPORATION | Actual shortage | 25MG | Updated Report | 2024-05-01 | 226027 |
LODALIS | BAUSCH HEALTH, CANADA INC. | Anticipated shortage | 625MG | New Report | 2024-05-01 | 226788 |
EFUDEX | BAUSCH HEALTH, CANADA INC. | Actual shortage | 5% | New Report | 2024-05-01 | 226785 |
SOLIFENACIN | SANIS HEALTH INC | Actual shortage | 5MG | Updated Report | 2024-05-01 | 217809 |
SERTRALINE | SANIS HEALTH INC | Actual shortage | 100MG | Updated Report | 2024-05-01 | 216254 |
RABEPRAZOLE EC | SANIS HEALTH INC | Actual shortage | 10MG | Updated Report | 2024-05-01 | 214284 |
ESOMEPRAZOLE | SANIS HEALTH INC | Actual shortage | 40MG | Updated Report | 2024-05-01 | 220681 |
ALFUZOSIN | SANIS HEALTH INC | Actual shortage | 10MG | Updated Report | 2024-05-01 | 223485 |
COTAZYM | ORGANON CANADA INC. | Anticipated shortage | 35000UNIT 40000UNIT 10000UNIT | Updated Report | 2024-05-01 | 225096 |
CELESTONE SOLUSPAN | ORGANON CANADA INC. | Resolved | 3MG 3MG | Updated Report | 2024-05-01 | 211633 |
BURINEX | KARO PHARMA AB | Actual shortage | 1MG | New Report | 2024-05-01 | 226761 |
THYROGEN | SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC | Resolved | 0.9MG | Updated Report | 2024-05-01 | 191764 |
SANDOZ EZETIMIBE | SANDOZ CANADA INCORPORATED | Resolved | 10MG | Updated Report | 2024-05-01 | 222611 |
SANDOZ OLMESARTAN | SANDOZ CANADA INCORPORATED | Resolved | 20MG | Updated Report | 2024-05-01 | 223197 |
SANDOZ RIVASTIGMINE PATCH 10 | SANDOZ CANADA INCORPORATED | Resolved | 9.5MG | Updated Report | 2024-05-01 | 224174 |
SOLU-CORTEF | PFIZER CANADA ULC | Actual shortage | 250MG | Updated Report | 2024-05-01 | 225355 |
Discontinuation Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
AUBAGIO | SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC | To be discontinued | 14MG | New Report | 2024-05-02 | 226847 |
SANDOZ OXYCODONE/ACETAMINOPHEN | SANDOZ CANADA INCORPORATED | Discontinued | 325MG 5MG | Updated Report | 2024-05-02 | 226748 |
SANDOZ OXYCODONE/ACETAMINOPHEN | SANDOZ CANADA INCORPORATED | Discontinued | 325MG 5MG | Updated Report | 2024-05-02 | 226753 |
HUMULIN R | ELI LILLY CANADA INC | To be discontinued | 100UNIT | New Report | 2024-05-02 | 224344 |
SANDOZ D 10 000 | SANDOZ CANADA INCORPORATED | Discontinued | 10000UNIT | Updated Report | 2024-05-02 | 226738 |